|Print Page | Close Window|
Corporate ProfileOcular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
NASDAQ OCUL (Common Stock)
$4.91 - 0.04
Data provided by Nasdaq. Minimum 15 minutes delayed.